SCARB1 and neoplasm: Whereas the Jurkat-GFP tumor cell infiltrates in the liver do not change upon 92R mAb-treatment (Supplementary Figure 2B), the infiltrates of MOLT4-GFP cells in the liver of isotype control treated animals shows a completely different distribution pattern and is abrogated by treatment with either 92R mAb or Srb1 (Supplementary Figures 2A, 3B).